More evidence combination DOAC & antiplatelet should not use used together in patients with Atrial Fibrillation and Stable Coronary Artery Disease, as there is no benefit in ischaemic events but significant increase in bleeding risk #ESCCongress #EPIC-CAD nejm.org/doi/full/10.10…

At least 1 Factor Xi inhibitior is *NOT* ready for the big show in AF.

MRA in HFrEF RALES 1999 ⬇️ ☠️ HR 0.70 (0.60-0.83) p<0.001 EMPHASIS-HF 2010 ⬇️ ☠️ HR 0.76 (0.62-0.93) p=0.008 Class 1 in guidelines for HFrEF Cost of Rx ~$40 per year Use in routine US clinical practice in eligible patients without CI/intolerance in 2024? <40% 🚨🚨🚨🚨🚨

Never underestimate the power of clinical inertia. Other than cost, few barriers persistently exist in implementing GDMT

Brush up on your knowledge of DOAC drug-drug interactions. Our newly updated Rapid Resource has you covered! This essential guide provides: 🔸 Clear guidance on drug-drug interactions with DOACs 🔸 Detailed explanation of interaction mechanisms, including pharmacodynamic and

Thanks for the feedback everyone, we were able to talk to the publisher and get the #AKIP list is open access for the week! Please retweet and share so we can increase access and visibility! See thread below journals.sagepub.com/doi/full/10.11…

Long needed! pubmed.ncbi.nlm.nih.gov/39230007/ (List is in the supplementary materials, Excel)

#flozinate

Well said Keith Wilson! I feel so fortunate to be part of the #HMICommunity

Check out this fun and engaging tweetorial that I put together discussing #cvCoag treatment options and current limitations of #DOAC therapy. Test your knowledge with fun multiple-choice questions and earn #CME!

✨Cardio-Oncology & Heart Failure: A Scientific Statement from the HFSA‼️ #CardioOncology #HF #PositionPaper #Cancer

I missed this: great JACC Journals review on GU infxn w SGLT2i. SGLT2i is assoc w⬆️risk of GMI but NOT UTI or Fournier’s. #GDMTWorks for #HFrEF UCSF Cardiology UCSF IM Chiefs Gregg Fonarow MD Steve Greene Andrew J Sauer MD jacc.org/doi/abs/10.101…

Rapid Uptitration of Guideline-Directed Medical Therapies in Acute Heart Failure With and Without Atrial Fibrillation Rapid GDMT uptitration before and early after discharge is feasible, is safe, and may improve outcomes regardless of AF presence or type jacc.org/doi/10.1016/j.…

European Society of Clinical Pharmacy: ‘the prescribing pharmacist: a prescription for better patient care’ @IntJClinPharm Ankie Hazen link.springer.com/article/10.100…

It's an honor to moderate Clinical Pearls. Thanks for the shout out Paul Huiras, PharmD, BCPS and thanks to ASHP for the opportunity 🙏🏽

Honored to work with this all star group! Arthur Allen Geoff Barnes Utibe R. Essien, MD MPH Anticoagulation Forum

SGLT2i: Practice Points in CKD KDIGO Nephrology Journal Club infographic by Anant SSP MD DM 🇮🇳

1/ Cardiovascular diseases, including heart disease and stroke, claim more lives in the U.S. than all forms of cancer and accidental deaths – the #2 and #3 causes of death – combined. The 2025 Statistics Update is now available.

Heart failure and obesity: Translational approaches and therapeutic perspectives. A scientific statement of the Heart Failure Association ESC Novel therapies inducing weight loss appear to have favourable effects on health status and cardiovascular risk onlinelibrary.wiley.com/doi/10.1002/ej…

Our statement is out: 2025 Concise Clinical Guidance: An American College of Cardiology Expert Consensus Statement on Medical Weight Management for Optimization of Cardiovascular Health 📎 jacc.org/doi/10.1016/j.… Honour to cochaired this with Olivia Gilbert ♥️